These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21112756)

  • 1. Admission profile and management of community acquired pneumonia in Nigeria--5 year experience in a tertiary hospital.
    Onyedum CC; Chukwuka JC
    Respir Med; 2011 Feb; 105(2):298-302. PubMed ID: 21112756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community acquired pneumonia. A perspective for general practice.
    Tsirgiotis E; Ruffin R
    Aust Fam Physician; 2000 Jul; 29(7):639-45. PubMed ID: 10914447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J
    Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
    Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
    Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
    Nathwani D; Rubinstein E; Barlow G; Davey P
    Clin Infect Dis; 2001 Mar; 32(5):728-41. PubMed ID: 11229840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009.
    Froes F; Diniz A; Mesquita M; Serrado M; Nunes B
    Eur Respir J; 2013 May; 41(5):1141-6. PubMed ID: 22878871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Community-acquired pneumonia in hospitalized adult patients. Clinical presentation and prognostic factors].
    Saldías F; Mardónez JM; Marchesse M; Viviani P; Farías G; Díaz A
    Rev Med Chil; 2002 Dec; 130(12):1373-82. PubMed ID: 12611238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).
    Kozma CM; Dickson M; Raut MK; Mody S; Fisher AC; Schein JR; Mackowiak JI
    J Med Econ; 2010; 13(4):719-27. PubMed ID: 21091099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of admission for paediatric pneumonia in a setting of human immunodeficiency virus infection.
    Kitchin OP; Wessels F; Masekela R; Becker P; Green RJ
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1702-7. PubMed ID: 22118183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical judgment versus the Pneumonia Severity Index in making the admission decision.
    Seymann G; Barger K; Choo S; Sawhney S; Davis D
    J Emerg Med; 2008 Apr; 34(3):261-8. PubMed ID: 18180134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
    Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
    Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia.
    Polverino E; Torres Marti A
    Minerva Anestesiol; 2011 Feb; 77(2):196-211. PubMed ID: 21242952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
    Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
    J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired pneumonia in Oklahoma: characteristics and management of hospitalized Medicare beneficiaries.
    Bratzler DW; Murray CK; Bumpus LJ; Moore LL
    J Okla State Med Assoc; 1996 Mar; 89(3):87-92. PubMed ID: 8919852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Community-acquired pneumonia: outcomes and costs].
    Putinati S; Ballerin L; Gualandi M; Battaglia G; Piattella M; Potena A
    Recenti Prog Med; 2002 Mar; 93(3):162-5. PubMed ID: 11942165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.